MedTrace Logo

Cervical and Endometrial Injection for Sentinel Lymph Node Detection in Endometrial Cancer

NCT03900104 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 81

Last updated 2020-02-20

No results posted yet for this study

Summary

The investigators think that trans-cervical endometrial tracer injection will cause more paraaortic sentinel lymph node detection. Also, this application is easy, cost-effective and safer than hysteroscopic method. Transtubal tumor spearing will not occur with this method.

Conditions

Interventions

PROCEDURE

Transcervical endometrial injection of technetium 99 m-labeled human albumin colloid particles

Transcervical endometrial injection of technetium 99 m-labeled human albumin colloid particles, in 5 mL saline, 2 hours before surgery. Injection performed with a trans-cervical catheter

PROCEDURE

Cervical injection of technetium 99 m-labeled human albumin colloid particles

Cervical injection of technetium 99 m-labeled human albumin colloid particles, in 5 mL saline, 2 hours before surgery.

Sponsors & Collaborators

  • Kocaeli University

    lead OTHER

Principal Investigators

  • Şener Gezer, M.D · Kocaeli University

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-01
Primary Completion
2020-01-01
Completion
2020-01-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03900104 on ClinicalTrials.gov